Clinical Trial Update: Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on ascending doses of ceralasertib in combination with chemotherapy or other anti-cancer agents in advanced solid malignancies, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• Ceralasertib (ceralasertib)

Snippet

Sponsor: AstraZeneca | Conditions: Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING